Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
about
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionRole of Interleukin-1 in Radiation-Induced Cardiomyopathy.The IL-1RI Co-Receptor TILRR (FREM1 Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
P2860
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@en
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@nl
type
label
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@en
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@nl
prefLabel
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@en
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@nl
P2860
P356
P1476
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
@en
P2093
Antonio Abbate
P2860
P304
P356
10.1093/EURHEARTJ/EHU369
P577
2014-09-08T00:00:00Z